Proteostasis Therapeutics, Inc. Soared
Tue, Dec 24, 2019 at 05:30 PM
Proteostasis Therapeutics, Inc. (PTI:NASDAQ) rocketted at $2.25, representing a gain of 51%. On Mon 23 Dec 19, PTI:NASDAQ hit a New 2-Week Intraday Low of $1.24. The stock appeared on our News Catalysts scanner on Fri 20 Dec 19 at 01:59 PM in the 'RECOMMENDATION' category. From Tue 03 Dec 19, the stock recorded 50.00% Up Days and 46.67% Green Days
The stock spiked on Wed 11 Dec 19 at $4.72 with a volume of 14M+.
About Proteostasis Therapeutics, Inc. (PTI:NASDAQ)
Proteostasis Therapeutics Inc operates in the healthcare sector of United States. Its business involves the discovery and development of therapeutics to correct the imbalance of the protein biosynthesis process.
Top 10 Gainers:
- Microbot Medical Inc. (MBOT:NASDAQ), 61.03%
- Proteostasis Therapeutics, Inc. (PTI:NASDAQ), 51.01%
- CLPS Incorporation (CLPS:NASDAQ), 46.12%
- Lineage Cell Therapeutics, Inc. (LCTX:NYSEMKT), 34.52%
- TMSR Holding Company Limited (TMSR:NASDAQ), 33.33%
- Sienna Biopharmaceuticals, Inc. (SNNA:NASDAQ), 30.7%
- Soleno Therapeutics, Inc. (SLNO:NASDAQ), 28.57%
- Cassava Sciences, Inc. (SAVA:NASDAQ), 26.74%
- Hi-Crush Inc. (HCR:NYSE), 26.25%
- Applied Genetic Technologies Corporation (AGTC:NASDAQ), 23.98%